Omega-3 supplements during breast cancer treatment
Part of Cancer, Skin clinical trials.
This trial tests whether taking omega-3 fatty acid supplements during breast cancer treatment can change the way tumors use fats, potentially making treatment more effective. It is for people with early-stage invasive breast cancer who are about to start neoadjuvant therapy (treatment before surgery).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a breast tumor that is at least 1 cm (about the size of a pea).
- You have been diagnosed with invasive breast cancer (stage I to III) that has not spread to distant organs.
- You are planning to receive systemic treatment (like chemotherapy, hormone therapy, or targeted therapy) before surgery.
- You are not currently taking fish oil or omega-3 supplements (eating fish is okay).
- You have had a breast imaging test (like mammogram or ultrasound) within the last 60 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special anti-inflammatory diet can help reduce side effects in breast cancer survivors who are taking aromatase inhibitors after menopause. You would be randomly assigned to either follow the diet for 6 months or continue your usual diet, and your health will be monitored.
This trial tests whether taking supplements made from snakehead fish and turmeric can improve nutrition, reduce inflammation, and improve quality of life in women undergoing chemotherapy for breast cancer.
This study looks at how breast cancer patients use herbs and supplements during treatment and how these might affect their care. By answering one survey, you can help doctors learn more about personalized approaches for diverse populations.
This trial tests whether a specific nutrition supplement (amino acids and flavonoids) can lessen chemotherapy side effects, support nutrition, and improve quality of life in people with non-metastatic breast cancer. It focuses on women who are receiving certain chemotherapy medicines and can eat by mouth and attend regular visits.
This study tests whether a new type of PET/MRI scan can help doctors see how well breast cancer treatment is working. It is a platform study, meaning it can evaluate different treatments, but the focus is on using this advanced imaging to monitor response.
This trial tests whether a personalized nutrition and exercise program can improve treatment response by changing how your body and immune system react to breast cancer before surgery. It is for women newly diagnosed with early-stage breast cancer who will receive neoadjuvant therapy (treatment before surgery).
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.